Literature DB >> 22378671

Very early onset and severe complicated phenotype caused by a new spastic paraplegia 3A gene mutation.

Carlo Fusco1, Daniele Frattini, Enrico Farnetti, Davide Nicoli, Bruno Casali, Elvio Della Giustina.   

Abstract

Spastic paraplegia 3A is the second most common form of hereditary autosomal dominant spastic paraplegia. This form is mainly associated with an early age of onset and pure phenotype, although recently complicated forms were reported. We describe a patient carrying a new C>T P344S>CT mutation in exon 10 of the spastic paraplegia 3A gene with unusual, complicated, and extremely severe phenotype. At the last neurologic examination performed at 17 years of life, the patient disclosed spastic tetraparesis, sensorimotor axonal neuropathy, cognitive and cranial nerve impairment, mild pes cavus, and distal amyotrophy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378671     DOI: 10.1177/0883073811435245

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  Clinical features and genotype-phenotype correlation analysis in patients with ATL1 mutations: A literature reanalysis.

Authors:  Guo-Hua Zhao; Xiao-Min Liu
Journal:  Transl Neurodegener       Date:  2017-04-04       Impact factor: 8.014

Review 2.  Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview.

Authors:  Liena E O Elsayed; Isra Zuhair Eltazi; Ammar E Ahmed; Giovanni Stevanin
Journal:  Front Mol Biosci       Date:  2021-11-26

3.  Hereditary neuropathy with liability to pressure palsy (HNPP): report of a family with a new point mutation in PMP22 gene.

Authors:  Carlo Fusco; Carlotta Spagnoli; Grazia Gabriella Salerno; Elena Pavlidis; Daniele Frattini; Francesco Pisani
Journal:  Ital J Pediatr       Date:  2017-10-27       Impact factor: 2.638

4.  Long-term follow-up until early adulthood in autosomal dominant, complex SPG30 with a novel KIF1A variant: a case report.

Authors:  Carlotta Spagnoli; Susanna Rizzi; Grazia Gabriella Salerno; Daniele Frattini; Carlo Fusco
Journal:  Ital J Pediatr       Date:  2019-12-03       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.